Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

The DAHANCA 32 study: Electrochemotherapy for recurrent mucosal head and neck cancer

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Quality of life after thyroidectomy in patients with nontoxic nodular goiter: A prospective cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Versatility of the facial artery myomucosal island flap in neopharyngeal reconstruction

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Cricothyroidotomy - The emergency surgical airway

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. PET/CT prior to salvage surgery in recurrent head and neck squamous cell carcinoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Intratumor heterogeneity of PD-L1 expression in head and neck squamous cell carcinoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Salivary gland carcinomas with unusual presentations

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Adherence to preventive swallowing exercises for head and neck cancer patients undergoing (chemo)radiotherapy treatment

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Very Early Response Evaluation by PET/MR in Patients with Lung Cancer-Timing and Feasibility

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Electrochemotherapy is an established treatment for cutaneous tumors. This study aimed at determining efficacy of electrochemotherapy in recurrent head and neck cancer.

METHODS: Phase II clinical trial in patients with recurrent head and neck carcinomas with no curative treatment options. Electrochemotherapy was performed under general anesthesia. Primary endpoint was tumor response (CT scanning) evaluated at week 8. Secondary endpoints included biopsy results, MRI and fluorodeoxyglucose-positron emission tomography scanning, safety, toxicity, pain score, and quality-of-life questionnaires.

RESULTS: Of 26 patients treated, 5 (19%) achieved complete response, 10 (39%) partial response, resulting in an objective response of 58%. Two responders remain without recurrence. No serious adverse events occurred during treatment. Four events occurred posttreatment: one bleeding episode, two episodes with mucosal swelling, and one patient died due to disease progression.

CONCLUSION: Electrochemotherapy is efficient against local recurrence of head and neck cancer with an overall response rate of 58%.

Original languageEnglish
JournalHead and Neck
Volume41
Issue number2
Pages (from-to)329-339
ISSN1043-3074
DOIs
Publication statusPublished - 2019

ID: 56116766